BioCentury
ARTICLE | Company News

GVK Biosciences, Onconova Therapeutics deal

January 14, 2013 8:00 AM UTC

Onconova and CRO GVK partnered to develop two small molecules to treat cancer. Onconova will provide the targets, while GVK will develop the molecules through IND candidate selection. GVK is eligible ...